Client of a consultant lobbyist
Canadian Pharmaceutical Manufacturers and Exporters Alliance
- Meetings this Parliament
- 8
- With MPs
- 3
- Since Nov 2021
- 8
- Active registrations
- 1
Most recent reported meeting: Aug 28, 2026.
Lobbying by Canadian Pharmaceutical Manufacturers and Exporters Alliance: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
Consultant In effect since Nov 26, 2025
Consultant Terry Creighton
Consultant lobbyists
- Terry Creighton
Institutions they may lobby: Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Patented Medicine Prices Review Board (PMPRB), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC)
What they're lobbying on (4)Hide details
- Advocate for supportive economic and tax policy for Canada's pharmaceutical manufacturing sector.
- Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy
- Raise awareness of role of Canadian drug producers in exports to the U.S. and other parts of the world. Advocate for including Canada's drug exports as part of CUSMA negotiations
- Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers
Registration 962743-383617-2. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Terry Creighton · Consultant
- Ed Morgan · Director General, Health Canada (HC)
- Robyn Brake · Director, Health Canada (HC)
- Jeff Skene · Senior Executive Director, Health Canada (HC)
- Jean Francois Eddy · Analyst, Health Canada (HC)
Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers
-
Reported by Terry Creighton · Consultant
- Loris Mirella · Director, Global Affairs Canada (GAC)
- Arianne Reza · Deputy Minister, Public Services and Procurement Canada (PSPC)
- Joelle Paquette · Associate Assistant Deputy Minister, Public Services and Procurement Canada (PSPC)
- Gabrielle Dolgoy · Senior Trade Policy Officer, Global Affairs Canada (GAC)
Raise awareness of role of Canadian drug producers in exports to the U.S. and other parts of the world. Advocate for including Canada's drug exports as part of CUSMA negotiations Read more
Advocate for supportive economic and tax policy for Canada's pharmaceutical manufacturing sector.
Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy
-
Reported by Terry Creighton · Consultant
- Marjorie Michel · Minister of Health, Health Canada (HC)
- Jocelyne Voisin · Senior Assistant Deputy Minister, Health Canada (HC)
- Shalene Curtis-Micallef · Deputy Minister of Health, Health Canada (HC)
Advocate for supportive economic and tax policy for Canada's pharmaceutical manufacturing sector. Read more
Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers
Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy
Raise awareness of role of Canadian drug producers in exports to the U.S. and other parts of the world. Advocate for including Canada's drug exports as part of CUSMA negotiations
-
Reported by Terry Creighton · Consultant
- Helena Jaczek · Member of Parliament
- Jacques Ramsay · Member of Parliament
- Madeleine Chenette · Member of Parliament
- Doug Eyolfson · Member of Parliament
and 2 moreShow fewer
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
- Guillaume Couillard · Director General, Patented Medicine Prices Review Board (PMPRB)
Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers Read more
Advocate for supportive economic and tax policy for Canada's pharmaceutical manufacturing sector.
Raise awareness of role of Canadian drug producers in exports to the U.S. and other parts of the world. Advocate for including Canada's drug exports as part of CUSMA negotiations
Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy
-
Reported by Terry Creighton · Consultant
- Pamela Aung-Thin · ADM, Health Canada (HC)
- David Lee · Chief Regulatory Officer, Health Canada (HC)
Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers
-
Reported by Terry Creighton · Consultant
- Karim Bardeesy · MP
- Paul Moen · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee · ADM, Innovation, Science and Economic Development Canada (ISED)
- Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Advocate for supportive economic and tax policy for Canada's pharmaceutical manufacturing sector. Read more
Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers
Raise awareness of role of Canadian drug producers in exports to the U.S. and other parts of the world. Advocate for including Canada's drug exports as part of CUSMA negotiations
Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy
-
Reported by Terry Creighton · Consultant
- Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee · ADM, Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Raise awareness of role of Canadian drug producers in exports to the U.S. and other parts of the world. Advocate for including Canada's drug exports as part of CUSMA negotiations Read more
Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy
Advocate for supportive economic and tax policy for Canada's pharmaceutical manufacturing sector.
Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers
-
Reported by Terry Creighton · Consultant
- Greg Orencsak · Deputy Minister, Health Canada (HC)
- Pamela Aung-Thin · ADM, Health Canada (HC)
- Daniel MacDonald · ADM Pharmaceutical Strategy, Health Canada (HC)
Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers Read more
Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.